Microbix Biosystems (TSE:MBX) Trading Down 13.2% – Here’s Why

Microbix Biosystems Inc. (TSE:MBX)’s share price was down 13.2% on Thursday . The stock traded as low as C$0.23 and last traded at C$0.23. Approximately 173,500 shares changed hands during trading, an increase of 206% from the average daily volume of 56,636 shares. The stock had previously closed at C$0.27.

Microbix Biosystems Stock Performance

The company’s 50 day simple moving average is C$0.24 and its 200 day simple moving average is C$0.24. The company has a debt-to-equity ratio of 30.47, a quick ratio of 5.57 and a current ratio of 7.51. The stock has a market cap of C$30.48 million, a PE ratio of -7.33 and a beta of 0.48.

Microbix Biosystems (TSE:MBX) last announced its earnings results on Thursday, May 14th. The company reported C($0.01) earnings per share for the quarter. The business had revenue of C$3.38 million during the quarter. Microbix Biosystems had a negative return on equity of 14.88% and a negative net margin of 25.48%. Analysts expect that Microbix Biosystems Inc. will post 0.02 earnings per share for the current year.

Microbix Biosystems Company Profile

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.